SCHEMBL6364200

SCHEMBL6364200

Cc1cn([C@H]2CC(OCO)[C@@H](COC(c3ccccc3)(c3ccccc3)c3ccccc3)O2)c(=O)[nH]c1=O

nearest known ligand 0.64

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RNASE1 P07998 1/20 0.59
TK1 P04183 8/20 0.51
TK2 O00142 4/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6827418 0.94 RNASE1 (0.53) RNASE1TK1TK2
SCHEMBL9014404 0.90 RNASE1 (0.55) RNASE1TK1TK2
SCHEMBL10446918 0.90 RNASE1 (0.55) RNASE1TK1TK2
SCHEMBL8591071 0.89 RNASE1 (0.55) RNASE1TK1TK2
SCHEMBL8377239 0.88 RNASE1 (0.54) RNASE1TK1TK2
SCHEMBL7917157 0.88 RNASE1 (0.54) RNASE1TK1TK2
SCHEMBL7922840 0.88 TK1 (0.67) RNASE1TK1TK2
SCHEMBL7922838 0.88 TK1 (0.67) RNASE1TK1TK2
SCHEMBL10446716 0.88 POLB (0.58) TK1
SCHEMBL6334503 0.88 POLB (0.58) TK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050176941-A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof TAKESHI IMANISHI (JP) 2005-08-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050176941-A1 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof RNGTT, NSUN2, SNRPE RNASE1 98/4885TK1 259/4885TK2 1101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.